Monte Rosa Therapeutics
Earnings Surprise
Analysts estimated GLUE earnings of $-0.36 per share this quarter (Q4). GLUE's actual earnings were $-0.56 per share.
GLUE EPS surprise of -56.16%Analysts estimated GLUE earnings of $-0.38 per share this quarter (Q3). GLUE's actual earnings were $-0.33 per share.
GLUE EPS surprise of 13.20%Analysts estimated GLUE earnings of $-0.39 per share this quarter (Q2). GLUE's actual earnings were $-0.15 per share.
GLUE EPS surprise of 61.87%Analysts estimated GLUE earnings of $-0.34 per share this quarter (Q1). GLUE's actual earnings were $0.56 per share.
GLUE EPS surprise of 262.93%Analysts estimated GLUE earnings of $-0.02 per share this quarter (Q4). GLUE's actual earnings were $0.23 per share.
GLUE EPS surprise of 1078.72%Analysts estimated GLUE earnings of $-0.50 per share this quarter (Q3). GLUE's actual earnings were $-0.29 per share.
GLUE EPS surprise of 41.56%Analysts estimated GLUE earnings of $-0.55 per share this quarter (Q2). GLUE's actual earnings were $-0.43 per share.
GLUE EPS surprise of 21.93%Analysts estimated GLUE earnings of $-0.58 per share this quarter (Q1). GLUE's actual earnings were $-0.53 per share.
GLUE EPS surprise of 9.29%Analysts estimated GLUE earnings of $-0.34 per share this quarter (Q4). GLUE's actual earnings were $-0.58 per share.
GLUE EPS surprise of 69.89%Analysts estimated GLUE earnings of $-0.74 per share this quarter (Q3). GLUE's actual earnings were $-0.70 per share.
GLUE EPS surprise of -5.17%